Report Overview
Report Summary
Summary
Packaging can be engineered to help reduce the risks of package pilferage or the theft and resale of products: Some package constructions are more resistant to pilferage and some have pilfer indicating seals. Counterfeit consumer goods, unauthorized sales (diversion), material substitution and tampering can all be reduced with these anti-counterfeiting technologies.
On the basis of technology, the global anti-conterfeit pharmaceutical packaging market can be divided into RFID, security printing and graphics, hologram, mass encoding and security inks and others. The RFID sector of the market was estimated to worth over US$ 300 Mn in 2017 and is expected to increase at a CAGR of 11.53% over the forecast period.
The global Anti-counterfeit Pharmaceutical Packaging market was 2030 million US$ in 2020 and is expected to 4870 million US$ by the end of 2027, growing at a CAGR of 11.5% between 2021 and 2027.
This report studies the Anti-counterfeit Pharmaceutical Packaging market size (value and volume) by players, regions, product types and end industries, history data 2017-2020 and forecast data 2021-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Anti-counterfeit Pharmaceutical Packaging in these regions, from 2017 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
3M
Aesica
Alien Technology
AlpVision
Authentix
Avery Dennison
CFC International
Digimarc
Impinj
SICPA
By the product type, the market is primarily split into
RFID
Security Inks & Coatings
Security Printing & Graphics
Hologram
Mass Encoding
Others
By the end users/application, this report covers the following segments
Covert Features
Overt Features
Forensic Markers
Tamper Evidence
Track & Trace Technologies
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Anti-counterfeit Pharmaceutical Packaging market size (value & volume) by company, key regions/countries, products and application, history data from 2017 to 2020, and forecast to 2027.
To understand the structure of Anti-counterfeit Pharmaceutical Packaging market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-counterfeit Pharmaceutical Packaging manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-counterfeit Pharmaceutical Packaging with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anti-counterfeit Pharmaceutical Packaging submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Anti-counterfeit Pharmaceutical Packaging are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-counterfeit Pharmaceutical Packaging market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Anti-counterfeit Pharmaceutical Packaging market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table Of Contents
Table of Contents
1 Anti-counterfeit Pharmaceutical Packaging Market Overview
1.1 Anti-counterfeit Pharmaceutical Packaging Product Overview
1.2 Anti-counterfeit Pharmaceutical Packaging Market Segment by Type
1.2.1 RFID
1.2.2 Security Inks & Coatings
1.2.3 Security Printing & Graphics
1.2.4 Hologram
1.2.5 Mass Encoding
1.2.6 Others
1.3 Global Anti-counterfeit Pharmaceutical Packaging Market Size by Type
1.3.1 Global Anti-counterfeit Pharmaceutical Packaging Sales and Growth by Type
1.3.2 Global Anti-counterfeit Pharmaceutical Packaging Sales and Market Share by Type (2017-2020)
1.3.3 Global Anti-counterfeit Pharmaceutical Packaging Revenue and Market Share by Type (2017-2020)
1.3.4 Global Anti-counterfeit Pharmaceutical Packaging Price by Type (2017-2020)
2 Global Anti-counterfeit Pharmaceutical Packaging Market Competition by Company
2.1 Global Anti-counterfeit Pharmaceutical Packaging Sales and Market Share by Company (2017-2020)
2.2 Global Anti-counterfeit Pharmaceutical Packaging Revenue and Share by Company (2017-2020)
2.3 Global Anti-counterfeit Pharmaceutical Packaging Price by Company (2017-2020)
2.4 Global Top Players Anti-counterfeit Pharmaceutical Packaging Manufacturing Base Distribution, Sales Area, Product Types
2.5 Anti-counterfeit Pharmaceutical Packaging Market Competitive Situation and Trends
2.5.1 Anti-counterfeit Pharmaceutical Packaging Market Concentration Rate
2.5.2 Global Anti-counterfeit Pharmaceutical Packaging Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Anti-counterfeit Pharmaceutical Packaging Company Profiles and Sales Data
3.1 3M
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.1.3 3M Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Aesica
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.2.3 Aesica Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Alien Technology
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.3.3 Alien Technology Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 AlpVision
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.4.3 AlpVision Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Authentix
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.5.3 Authentix Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Avery Dennison
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.6.3 Avery Dennison Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 CFC International
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.7.3 CFC International Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Digimarc
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.8.3 Digimarc Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Impinj
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.9.3 Impinj Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 SICPA
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Anti-counterfeit Pharmaceutical Packaging Product Category, Application and Specification
3.10.3 SICPA Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
4 Anti-counterfeit Pharmaceutical Packaging Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Anti-counterfeit Pharmaceutical Packaging Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Anti-counterfeit Pharmaceutical Packaging Sales and Revenue by Regions
4.2.1 Global Anti-counterfeit Pharmaceutical Packaging Sales and Market Share by Regions (2017-2020)
4.2.2 Global Anti-counterfeit Pharmaceutical Packaging Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Anti-counterfeit Pharmaceutical Packaging Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Anti-counterfeit Pharmaceutical Packaging Application/End Users
5.1 Anti-counterfeit Pharmaceutical Packaging Segment by Application
5.1.1 Covert Features
5.1.2 Overt Features
5.1.3 Forensic Markers
5.1.4 Tamper Evidence
5.1.5 Track & Trace Technologies
5.2 Global Anti-counterfeit Pharmaceutical Packaging Product Segment by Application
5.2.1 Global Anti-counterfeit Pharmaceutical Packaging Sales by Application
5.2.2 Global Anti-counterfeit Pharmaceutical Packaging Sales and Market Share by Application (2017-2020)
6 Global Anti-counterfeit Pharmaceutical Packaging Market Forecast
6.1 Global Anti-counterfeit Pharmaceutical Packaging Sales, Revenue Forecast (2021-2027)
6.1.1 Global Anti-counterfeit Pharmaceutical Packaging Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Anti-counterfeit Pharmaceutical Packaging Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Anti-counterfeit Pharmaceutical Packaging Forecast by Regions
6.2.1 North America Anti-counterfeit Pharmaceutical Packaging Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Anti-counterfeit Pharmaceutical Packaging Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Anti-counterfeit Pharmaceutical Packaging Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Anti-counterfeit Pharmaceutical Packaging Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Anti-counterfeit Pharmaceutical Packaging Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Anti-counterfeit Pharmaceutical Packaging Forecast by Type
6.3.1 Global Anti-counterfeit Pharmaceutical Packaging Sales and Revenue Forecast by Type (2021-2027)
6.3.2 RFID Gowth Forecast
6.3.3 Security Inks & Coatings Gowth Forecast
6.4 Anti-counterfeit Pharmaceutical Packaging Forecast by Application
6.4.1 Global Anti-counterfeit Pharmaceutical Packaging Sales Forecast by Application (2021-2027)
6.4.2 Global Anti-counterfeit Pharmaceutical Packaging Forecast in Covert Features
6.4.3 Global Anti-counterfeit Pharmaceutical Packaging Forecast in Overt Features
7 Anti-counterfeit Pharmaceutical Packaging Upstream Raw Materials
7.1 Anti-counterfeit Pharmaceutical Packaging Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Anti-counterfeit Pharmaceutical Packaging Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer